Colony Group’s Bristol-Myers Squibb BMY Stock Holding History

Colony Group’s Portfolio BMY Stock Details BMY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	$12.3M	Sell	212,434 -622	-0.3%	-$38.1K	0.19%	122
2023 Q2	$13.6M	Sell	213,056 -268	-0.1%	-$18K	0.19%	125
2023 Q1	$14.8M	Sell	213,324 -18,318	-8%	-$1.29M	0.22%	119
2022 Q4	$16.7M	Buy	231,642 +5,867	+3%	+$442K	0.23%	110
2022 Q3	$16.1M	Buy	225,775 +12,778	+6%	+$927K	0.28%	90
2022 Q2	$16.4M	Buy	212,997 +16,888	+9%	+$1.29M	0.28%	92
2022 Q1	$14.3M	Buy	196,109 +14,117	+8%	+$948K	0.21%	112
2021 Q4	$11.3M	Buy	181,992 +47,472	+35%	+$2.78M	0.2%	99
2021 Q3	$7.96M	Sell	134,520 -1,586	-1%	-$104K	0.15%	114
2021 Q2	$9.1M	Buy	136,106 +514	+0.4%	+$33.5K	0.18%	113
2021 Q1	$8.56M	Sell	135,592 -5,179	-4%	-$322K	0.18%	114
2020 Q4	$8.73M	Sell	140,771 -5,073	-3%	-$312K	0.2%	103
2020 Q3	$8.79M	Sell	145,844 -4,253	-3%	-$256K	0.23%	100
2020 Q2	$8.83M	Sell	150,097 -2,122	-1%	-$127K	0.26%	98
2020 Q1	$8.48M	Sell	152,219 -31,285	-17%	-$1.91M	0.28%	96
2019 Q4	$11.8M	Buy	183,504 +18,192	+11%	+$1.04M	0.3%	91
2019 Q3	$8.38M	Buy	165,312 +50,038	+43%	+$2.35M	0.27%	101
2019 Q2	$5.23M	Buy	115,274 +107,458	+1,375%	+$5.01M	0.17%	155
2019 Q1	$373K	Buy	7,816 +3,792	+94%	+$189K	0.02%	465
2018 Q4	$209K	Sell	4,024 -3,038	-43%	-$163K	0.01%	466
2018 Q3	$438K	Sell	7,062 -485	-6%	-$28.8K	0.02%	364
2018 Q2	$418K	Buy	7,547 +8	+0.1%	+$432	0.02%	364
2018 Q1	$477K	Buy	7,539 +124	+2%	+$7.98K	0.03%	341
2017 Q4	$454K	Buy	7,415 +757	+11%	+$47.3K	0.03%	333
2017 Q3	$424K	Sell	6,658 -3,236	-33%	-$189K	0.03%	314
2017 Q2	$551K	Buy	+9,894	New	+$538K	0.04%	273
2016 Q4	–	Sell	-5,857	Closed	-$316K	–	282
2016 Q3	$316K	Buy	5,857 +4	+0.1%	+$257	0.04%	214
2016 Q2	$431K	Buy	5,853 +1,290	+28%	+$91.2K	0.05%	179
2016 Q1	$291K	Sell	4,563 -407	-8%	-$25.7K	0.03%	201
2015 Q4	$342K	Buy	4,970 +4,934	+13,706%	+$326K	0.03%	300
2015 Q3	$2K	Sell	36 -271	-88%	-$17.2K	﹤0.01%	758
2015 Q2	$20K	Hold	307	–	–	﹤0.01%	537
2015 Q1	$20K	Hold	307	–	–	﹤0.01%	508
2014 Q4	$18K	Sell	307 -117	-28%	-$6.6K	﹤0.01%	526
2014 Q3	$22K	Sell	424 -2,678	-86%	-$134K	﹤0.01%	503
2014 Q2	$150K	Sell	3,102 -235	-7%	-$11.6K	0.02%	238
2014 Q1	$173K	Buy	3,337 +3,030	+987%	+$161K	0.02%	221
2013 Q4	$16K	Buy	+307	New	+$15.6K	﹤0.01%	427

Other funds holding BMY

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Colony Group's BMY Position: Q3 2023 in Review

Colony Group reduced its Bristol-Myers Squibb (BMY) stake by 0.29% in Q3 2023, selling an estimated $38.1K and leaving 212,434 shares worth $12.3M. The position accounts for 0.19% of the portfolio, ranked #122.

Colony Group first reported a position in BMY in Q4 2013 and has held it in 38 quarters since. The position peaked at $16.7M in Q4 2022. 2,387 funds tracked by Wall St. Rank hold BMY as of Q3 2023.

Colony Group held 212,434 shares of Bristol-Myers Squibb worth $12.3M as of Q3 2023.
Colony Group sold 622 Bristol-Myers Squibb shares in Q3 2023, an estimated $38.1K.
Bristol-Myers Squibb made up 0.19% of Colony Group's portfolio in Q3 2023, its #122 holding.
Colony Group first reported a position in Bristol-Myers Squibb in Q4 2013 and has held it in 38 quarters since.
Colony Group's Bristol-Myers Squibb position peaked at $16.7M in Q4 2022.
2,387 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q3 2023.

Based on Colony Group's 13F filing for Q3 2023, filed 14 Nov 2023.